Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

Smokers with opioid use disorder (OUD) have little success with smoking cessation, possibly due to interactions between nicotine and opioid receptor systems.

Smokers with OUD versus non-opioid substance use disorders (NOUD) have not been compared for response to smoking treatment.

Who Took Part

The age groups tagged for this paper are adults and middle-aged adults, both men and women.

The current study reports secondary analyses comparing smokers with OUD (n = 47) and NOUD (n = 90) on pretreatment smoking, alcohol and drug use, intolerance of physical discomfort, smoking medication adherence, and 3- and 6-month smoking and substance use outcomes (by VAR versus NRT).

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

The participants were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.

The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.

What Was Measured

The subject headings attached to it are Alcoholism, Comorbidity, Opioid-Related Disorders, Outcome Assessment, Health Care, Smoking, Smoking Cessation and Smoking Cessation Agents.

The authors tagged it with the keywords Opioid use disorder, Smoking treatment, Substance use disorder, Tolerance for discomfort, Transdermal nicotine and Varenicline.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2019 (Journal of substance abuse treatment), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.